<DOC>
	<DOCNO>NCT02532374</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics ( PK ) pharmacodynamics ( PD , i.e. , subjective effect ) profile , safety tolerability nicotine-containing aerosol deliver Platform 3 Liquid ( P3L ) system three different nicotine level smoke healthy subject Relation NicoretteÂ® .</brief_summary>
	<brief_title>Nicotine Pharmacokinetic Pharmacodynamics Profile , Safety Tolerability P3L</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subject Caucasian Smoking , healthy subject judge Investigator Subject smoke least 10 commercially available nonmenthol conventional/combustible cigarette ( CCs ) per day last 4 week Subject plan quit smoke next 3 month As per Investigator judgment , subject participate study reason ( e.g. , medical , psychiatric , and/or social reason ) Subject donate receipt whole blood blood product within 3 month prior Admission Visit Female subject pregnant breast feed Female subject agree use acceptable method effective contraception Female subject us estrogencontaining hormonal contraception hormone replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>nicotine absorption</keyword>
	<keyword>nicotine contain product</keyword>
	<keyword>conventional cigarette</keyword>
	<keyword>Nicorette</keyword>
	<keyword>combustible cigarette</keyword>
	<keyword>nicotine delivery system</keyword>
</DOC>